Resection of the medial wall of the cavernous sinus in functioning pituitary adenomas: Technical note and outcomes in a matched-cohort study
Introduction
Functioning pituitary adenomas comprise approximately half of pituitary adenomas and secrete one or more hormones produced by the anterior pituitary, namely prolactin (PRL), growth hormone (GH), adrenocorticotrophic hormone (ACTH), and thyroid-stimulating hormone (TSH) [14,23]. While they are histologically benign, these tumors are associated with a decreased quality of life and increased mortality rate as the patient is exposed to the pathophysiologic effects of hormone hypersecretion [1,3,7,10,11,14,16,23]. Timely biochemical control or cure of functioning pituitary adenomas is an important goal to ultimately improve morbidity and mortality from this disease.
A significant cause of failure after excision of these tumors is the presence of microscopic disease in the surrounding structures [2,8,9,13,20,21]. Microscopic deposits of tumor have been documented in the adjacent sellar dura, and the medial wall of the cavernous sinus [2,6,9,13,15,18,20,22]. It has been hypothesized that microscopic dural invasion decreases the rate of biochemical remission and increases the rate of recurrence after tumor excision [9,13,20,21]. Intuitively, resection of the medial wall of the cavernous sinus may potentially improve outcomes in terms of both biochemical cure and oncologic control.
Resection of the medial wall of the cavernous sinus is a highly technical and potentially morbid procedure due to the intimate relationship of the medial wall to important neurovascular structures including the internal carotid artery (ICA) and the venous plexi. The improvements provided by the fully endoscopic binasal approach to these tumors, however, have allowed for significantly improved lateral visualization and surgical manipulation to make this procedure a possibility [4,5]. Several groups have recently described their technique and presented the results of their early series [2,18,20].
The purpose of this manuscript is to describe our technique for the resection of the medial wall of the cavernous sinus using the BETS and discuss nuances to improve its safety and efficacy. We also compare the biochemical remission and tumor control rates in a cohort utilizing the technique with a cohort matched for tumor type, Knosp grade and size.
Section snippets
Patient population
After approval by the St. Michael’s Hospital Research Ethics Board (REB), the senior author’s (MDC) patient database was reviewed to identify patients with functioning pituitary adenomas who underwent resection of the medial wall of the cavernous sinus in addition to tumor excision using the BETS. Inclusion criteria included: (1) a diagnosis of a functioning pituitary adenoma supported by characteristic clinical manifestations and laboratory evidence of hormone hypersecretion, and confirmed by
Patient and tumor characteristics
A total of sixteen patients met the inclusion criteria. This cohort which underwent medial wall resection had a female predilection (4.1:1) and a mean age of 40.9 years (range: 25–76). The tumor type was GH-secreting pituitary adenoma in 38 %, ACTH-secreting pituitary adenoma in 31 %, and PRL-secreting pituitary adenoma in 31 %. The largest diameter of the tumors ranged from 0.4 to 2.8 cm and had a mean of 1.5 cm. The Knosp grade were as follows: 0 in 19 %, 1 in 13 %, 2 in 38 %, 3 in 13 % and 4
Nuances of technique and avoidance of complication
Our experience with the technique described shows that resection of the medial wall of the cavernous sinus is safe and feasible using the BETS if done by experienced surgeons.
The most common complication reported in previous publications describing the resection of the medial wall for the cavernous sinus for pituitary adenomas was cranial nerve paresis, which was seen in 1 case in Nagata’s series (transient CN III paresis) and in 4 cases in Cohen-Cohen’s cohort (CN VI palsy in most cases).915
Conclusion
Resection of the medial wall of the cavernous sinus is safe and technically feasible using the endonasal endoscopic approach when performed by experienced surgeons. This study also provides data that indicates that the present Knosp classification of cavernous sinus tumour involvement may not fully reflect microscopic invasion, which may be particularly important in establishing biochemical cure of functioning tumors. The value of medial wall resection in improving biochemical remission and
Declaration of Competing Interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers' bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the St. Michael’s Hospital Research Ethics Board and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Funding
No funding was received for this research.
Informed consent
No identifying information on any study subject was included in this article.
CRediT authorship contribution statement
Abdelsimar T. Omar: Conceptualization, Methodology, Validation, Formal analysis, Investigation, Resources, Data curation, Writing - original draft, Writing - review & editing, Visualization, Supervision, Project administration. David G. Munoz: Methodology, Data curation, Formal analysis, Investigation, Data curation, Writing - review & editing. Jeannette Goguen: Methodology, Formal analysis, Investigation, Data curation, Writing - review & editing. John M. Lee: Methodology, Formal analysis,
References (24)
- et al.
Removal of the medial wall of the cavernous sinus for functional pituitary adenomas: a technical report and pathologic significance
World Neurosurg.
(2019) - et al.
Mortality and morbidity in Cushing’s disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature
J. Clin. Endocrinol. Metab.
(2011) - et al.
The medial wall of the cavernous sinus. Part 2: selective medial wall resection in 50 pituitary adenoma patients
J. Neurosurg.
(2019) Quality-of-life assessment in patients with lesions of the cranial base
Skull Base
(1999)- et al.
The technique for endoscopic pituitary tumor removal
Neurosurg. Focus
(1996) - et al.
Outcomes of surgically treated giant pituitary tumours
Can. J. Neurol. Sci.
(2012) - et al.
Cavernous sinus invasion by pituitary adenomas--relationship between magnetic resonance imaging findings and histologically verified dural invasion
Neurol. Med. Chir. (Tokyo)
(1995) - et al.
Mortality in acromegaly: a metaanalysis
J. Clin. Endocrinol. Metab.
(2008) - et al.
Aggressive pituitary adenomas—diagnosis and emerging treatments
Nat. Rev. Endocrinol.
(2014) - et al.
Basis of persistent and recurrent Cushing disease: an analysis of findings at repeated pituitary surgery
J. Neurosurg.
(2002)